Antiviral TRIMs: Friend or Foe in Autoimmune and Autoinflammatory Disease?

Authors

Caroline A. Jefferies, Royal College of Surgeons in Ireland
Claire Wynne, Technological University DublinFollow
Rowan Higgs, Royal College of Surgeons in Ireland

Document Type

Article

Rights

Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence

Disciplines

1.4 CHEMICAL SCIENCES

Publication Details

NATURE REVIEWS

IMMUNOLOGY VOLUME 11 | SEPTEMBER 2011

doi:10.1038/nri3043.

Abstract

The concept that viral sensing systems, via their ability to drive pro-inflammatory cytokine and interferon production, contribute to the development of autoimmune and autoinflammatory disease is supported by a wide range of clinical and experimental observations. Recently, the tripartite motif-containing proteins (TRIMs) have emerged as having key roles in antiviral immunity — either as viral restriction factors or as regulators of pathways downstream of viral RNA and DNA sensors, and the inflammasome. Given their involvement in these pathways, we propose that TRIM proteins contribute to the development and pathology of autoimmune and autoinflammatory conditions, thus making them potential novel targets for therapeutic manipulation.

DOI

https://doi.org/10.1038/nri3043

Recommended Citation

Jefferies, C., Wynne, C, Higgs, R.: Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?. Nature Reviews, Immunology, 2011, Vol.11 (9), p. 617.25. doi: 10.1038/nri3043.